Delivery Order SPE2DX15D2103-BQ87
- Not listed
- This federal contract award, valued at $57,564.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of medical commodities, including prescription medications,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $6,537.24, is a delivery order for pharmaceutical and medical products to support military treatment facilities and federal healthcare providers. Amerisourcebergen is a major supplier of pharmaceutical and medical supplies to the U.S. government, with a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award, with ID SPE2DX15D2206|DZ19, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $96,626.16 firm fixed-price delivery order is for pharmaceutical and medical supply products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $49,473.84 firm-fixed-price delivery order is for the supply of various pharmaceutical products and medical supplies to support military treatment facilities and healthcare programs. Amerisourcebergen, through its Corporate Office division, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other...
- This federal contract award, with ID SPE2DX22D0020|SPE2D824F49DJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $124,037.22 firm-fixed-price delivery order contract is for the provision of pharmaceutical products and medical supplies to support various government healthcare programs and facilities, including military treatment facilities and veterans' hospitals. This award is not a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The award, with a total ceiling value of $10,375.50, is for the delivery of pharmaceutical products and medical supplies to support various government agencies and healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $8,201.59, is for the delivery of pharmaceutical and medical supplies to support military treatment facilities and healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, including a $999,999,999 IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $386,840.13, is for the delivery of pharmaceutical products and medical supplies to support various government agencies and healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to provide a wide range of prescription medications, over-the-counter...
- This federal contract award, with ID SPE2DX22D0059|SPE2D824F0BCB, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $118,460.43 firm fixed-price delivery order is not set aside and supports the supply of pharmaceutical products and medical supplies to federal healthcare programs, particularly military treatment facilities and veterans' healthcare. Amerisourcebergen, a major pharmaceutical distributor, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $99,238.05, provides for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs. This contract is a Delivery Order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DX15D2103Indefinite Delivery Contract
- SPE2DX15D2103-BQ87Delivery Order
This federal contract award, with the ID SPE2DX15D2103|BQ87, was granted by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, with a ceiling value of $86,986.19, is for the provision of pharmaceutical and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. This specific contract award is not designated with a set-aside requirement, indicating open competition. The Place of Performance is Chesterbrook, PA, USA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||